These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15642981)

  • 1. Current methods for detecting antibodies against erythropoietin and other recombinant proteins.
    Thorpe R; Swanson SJ
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):28-39. PubMed ID: 15642981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
    Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
    Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
    Rossert J; Casadevall N
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple screening test for the detection of erythropoietin antibodies.
    Meran S; Wonnacott A; Davies M; Ellis R; Phillips A
    Clin Nephrol; 2014 Sep; 82(3):215-20. PubMed ID: 23391321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
    Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
    Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red-cell aplasia and recombinant erythropoietin.
    Gershon SK; Luksenburg H; Coté TR; Braun MM
    N Engl J Med; 2002 May; 346(20):1584-6; author reply 1584-6. PubMed ID: 12015400
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin.
    Swanson SJ; Ferbas J; Mayeux P; Casadevall N
    Nephron Clin Pract; 2004; 96(3):c88-95. PubMed ID: 15056991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.
    Ferbas J; Thomas J; Hodgson J; Gaur A; Casadevall N; Swanson SJ
    Clin Vaccine Immunol; 2007 Sep; 14(9):1165-72. PubMed ID: 17634512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRCA in a patient treated with epoetin beta.
    Krüger A; Schröer W; Röhrs F; Vescio G
    Nephrol Dial Transplant; 2003 May; 18(5):1033-4. PubMed ID: 12686693
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red-cell aplasia due to anti-erythropoietin antibodies.
    Eckardt KU; Casadevall N
    Nephrol Dial Transplant; 2003 May; 18(5):865-9. PubMed ID: 12686654
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.
    Macdougall IC; Roger SD; de Francisco A; Goldsmith DJ; Schellekens H; Ebbers H; Jelkmann W; London G; Casadevall N; Hörl WH; Kemeny DM; Pollock C
    Kidney Int; 2012 Apr; 81(8):727-32. PubMed ID: 22336988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies.
    Hara A; Wada T; Kitajima S; Toyama T; Okumura T; Kitagawa K; Iwata Y; Sakai N; Furuichi K; Higuchi M; Kaneko S
    Am J Hematol; 2008 Sep; 83(9):750-2. PubMed ID: 18626921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
    Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
    J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological reaction against erythropoietin causing red-cell aplasia.
    Mercadal L; Sutton L; Casadevall N; Bagnis C; Jacobs C
    Nephrol Dial Transplant; 2002 May; 17(5):943. PubMed ID: 11981097
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin therapy: need for rationality and active surveillance.
    Cazzola M
    Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients developing anti-Epo antibodies during rHuEpo treatment do not express a polymorphic variant of Epo.
    Kadri Z; Mayeux P; Casadevall N; Chretien S
    Kidney Int; 2004 Feb; 65(2):742-3. PubMed ID: 14717954
    [No Abstract]   [Full Text] [Related]  

  • 20. The (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia.
    Summers S; Holdsworth S; Sharples E
    Nephrol Dial Transplant; 2008 Oct; 23(10):3053-5. PubMed ID: 18558625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.